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Abstract
Background: T2* magnetic resonance of tissue iron concentration has improved the outcome of transfusion
dependant anaemia patients. Clinical evaluation is performed at 1.5 T but scanners operating at 3 T are increasing
in numbers. There is a paucity of data on the relative merits of iron quantification at 3 T vs 1.5 T.
Methods: A total of 104 transfusion dependent anaemia patients and 20 normal volunteers were prospectively
recruited to undergo cardiac and liver T2* assessment at both 1.5 T and 3 T. Intra-observer, inter-observer and
inter-study reproducibility analysis were performed on 20 randomly selected patients for cardiac and liver T2*.
Results: Association between heart and liver T2* at 1.5 T and 3 T was non-linear with good fit (R2 = 0.954, p < 0.001
for heart white-blood (WB) imaging; R2 = 0.931, p < 0.001 for heart black-blood (BB) imaging; R2 = 0.993, p < 0.001 for
liver imaging). R2* approximately doubled between 1.5 T and 3 T with linear fits for both heart and liver (94, 94
and 105 % respectively). Coefficients of variation for intra- and inter-observer reproducibility, as well as inter-study
reproducibility trended to be less good at 3 T (3.5 to 6.5 %) than at 1.5 T (1.4 to 5.7 %) for both heart and liver T2*.
Artefact scores for the heart were significantly worse with the 3 T BB sequence (median 4, IQR 2–5) compared with
the 1.5 T BB sequence (4 [3–5], p = 0.007).
Conclusion: Heart and liver T2* and R2* at 3 T show close association with 1.5 T values, but there were more artefacts
at 3 T and trends to lower reproducibility causing difficulty in quantifying low T2* values with high tissue iron.
Therefore T2* imaging at 1.5 T remains the gold standard for clinical practice. However, in centres where only 3 T
is available, equivalent values at 1.5 T may be approximated by halving the 3 T tissue R2* with subsequent
conversion to T2*.
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Background
The transfusion dependent anemias are an important
worldwide cause of morbidity and mortality. In these pa-
tients, repeated blood transfusions can lead to substan-
tial iron tissue deposition which results in heart failure,
endocrine dysfunction and death [1]. Iron chelation therapy
is the crucial element of tissue siderosis prevention and
treatment. However, the existing drug regimens vary in
their efficacy, side-effects and potential toxicity. Therefore,
tailored chelation therapy administration is mandatory and
requires careful cardiac and liver iron content monitoring.
A number of studies have assessed the robustness, reli-
ability and reproducibility of myocardial and liver iron
content quantification by T2* magnetic resonance (MR)
[2–5]. Myocardial T2* has been used extensively to monitor
iron concentration in thalassemia patients [6]. The majority
of these studies have described iron content assessment
and its validation against tissue biopsy at 1.5 Tesla (T).
However, 3 T scanners are increasingly being used for clin-
ical indications, and may have some potential advantages,
including higher signal-to-noise ratio and shorter acquisi-
tion times. Set against these advantages are issues of in-
creased inhomogeneity in the magnetic fields of the magnet
(B0 and B1), increased specific absorption rate, increased
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susceptibility artefacts, and T2* shortening [7]. There is ra-
ther limited data about reproducibility and the comparative
robustness of myocardial and liver T2* and R2* at 3 T
[8–11]. The purpose of this study was therefore to re-
late T2* and R2* at 3 T vs 1.5 T in a substantial sample
size over a wide range of tissue iron concentrations,
with evaluation of image quality, and reproducibility.
Methods
Patients and study design
A total of 104 consecutive subjects were prospectively
recruited from referrals for siderosis screening. Further-
more, a group of 20 healthy volunteers was included.
Patients were already scheduled to undergo T2* MR
myocardial and liver content assessment at 1.5 T for
clinical purposes and a research scan at 3 T was performed
in addition. Inclusion criteria were: 1) age >18 years old
and 2) written and informed consent to participate. Exclu-
sion criteria were: 1) claustrophobia, 2) metallic implants or
permanent pacemaker and 3) inability to hold recumbent
position for >15 min. The study protocol was approved by
North-East Thames ethics committee.
Image acquisition
The T2* MR protocol consisted of two parts: 1) Myocar-
dial and liver iron content assessment on a 1.5 T Sonata
scanner 2) Repeated myocardial and liver iron burden
assessment with a 3 T Skyra scanner (both Siemens
Medical Systems, Erlangen, Germany).
Cardiac iron content
At 1.5 T, a four-element cardiac phase-array coil was
used. After routine localizer acquisitions, ECG gated
single breath hold multi-echo white blood (WB) and
black blood (BB) sequences were acquired at a single
mid-ventricular short axis slice with a 10 mm thickness
at eight separate echo times (2.6–16.74 ms, at 2.02 ms
increments). Both WB and BB sequences used a flip
angle of 35°, a matrix of 128 × 256 pixels, a field of view
(FOV) of 40 cm, repetition time of 20 ms between each
radiofrequency pulse and a sampling bandwidth of
810 Hz per pixel. For WB imaging, all echo times were
acquired exactly after the ECG R wave trigger. For BB
sequence acquisition, the double inversion pulses were
applied at the R wave trigger and the inversion time was
set to extend into diastole.
Table 1 Patient characteristics
Variables Patients Controls P-value
N = 104 N = 20
Age (years) 30 [23–53] 35 [26–43] 0.41
Gender (Male/Female) 55/45 10/10 0.67
Diagnosis
TM 47
SCA 15
Other hemoglobinopathy 20
MDS 4
Other 18
1.5 T WB Heart T2* 30.3 [22.6–36.8] 32.3 [28.9–36.7] 0.20
3 T WB Heart T2* 18.5 [11.8–24.3] 20.5 [18.3–24.3] 0.14
1.5 T Liver T2* 4.2 [1.8–8.6] 25.8 [23.1–28.0] <0.001
3 T Liver T2* 2.3 [0.9–4.7] 17.3 [14.8–21.4] <0.001
Data are expressed as median [interquartile range]. SCA sickle cell anemia,
MDS myelodysplasia syndrome, TM thalassemia major, WB white blood
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Fig. 1 a Association between cardiac T2* measurements at 1.5 T and 3 T using the white- blood sequence. The red line is the line of identity, and
the black line is the best fit regression line. b Association between cardiac R2* measurements at 1.5 T and 3 T using the white-blood sequence. The red
line is the line of identity, and the black line is the best fit regression line
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At 3 T, similar sequences were run on each patient. For
WB iron content assessment, echo time ranged from
2.69 ms to 18.86 ms with 2.31 ms increments with a
matrix of 256 × 256 pixels and a FOV of 40 cm. For the
BB acquisition, echo times ranges from 1.57 ms to
17.74 ms with similar time increments, matrix size and
FOV size. An acceleration factor of 2 was applied on all se-
quences. A small shimming box was used over the heart
to optimize the gradients settings and minimize artefacts.
Liver iron content
At 1.5 T, a single transaxial 10 mm thick slice through
the center of the liver was acquired at a succession of 20
echo times ranging from 0.97 ms to 13.89 ms with
0.68 ms increments, using a non-ECG-gated gradient
echo sequence with a flip angle of 20°, a matrix of
128 × 128 pixels a 40 cm FOV and a sampling band-
width 1950 Hz per pixel. The TR between 2 RF
pulses was 200 ms. A four channel-channel array coil
was used.
At 3 T, sequence parameters were comparable. Echo
time ranged from 1.0 ms to 16.5 ms with 1.41 ms incre-
ments. Matrix size was 128 × 128 pixels. Acceleration
factor two was applied on all acquisitions. As for cardiac
T2* and R2*, a small shimming box was used over the
liver to improve image acquisition quality.
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Fig. 2 a Association between cardiac T2* measurements at 1.5 T and at 3 T using the black-blood sequence. The red line is the line of identity,
and the black line is the best fit regression line. b Association between cardiac R2* measurements at 1.5 T and 3 T using the black-blood sequence.
The red line is the line of identity, and the black line is the best fit regression line
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Fig. 3 a Association between liver T2* measurements at 1.5 T and at 3 T. The red line is the line of identity, and the black line is the best fit
regression line. b Association between liver R2* measurements at 1.5 T and at 3 T. The red line is the line of identity, and the black line is the
best fit regression line
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Iron content quantification
The analysis of myocardial and liver T2* has been de-
scribed elsewhere [4, 12]. In brief, dedicated software
(Thalassaemia tools, a plug-in of CMRtools, Cardiovas-
cular Imaging Solutions, London) was used. The entire
thickness of the cardiac interventricular septum and a
large region of interest within the liver parenchyma
without blood vessels were selected to measure signal in-
tensity (SI) at each echo time. The SI was plotted against
echo time and a mono-exponential trendline was fitted to
the decay curve to derive T2* according to this equation:
SI ¼ SI0:eTE=T2
T2* was subsequently transformed into its reciprocal
R2* according to the equation:
T2 ¼ 1000=R2
Curve fitting was done according to the truncation
method [13]. In patients with cardiac T2* < 10 ms or liver
T2* < 3.3 ms at 1.5 T, a second-moment noise-corrected
model was used [14]. Cardiac T2* image quality was pro-
spectively evaluated for each acquisition according to the
following scoring scale: 0-unusable: uninterpretable im-
ages, 1-poor: heart just discernible, 2-average: severe septal
artefact, 3-good: moderate septal artefact, 4-very good:
mild septal artefact: 5-excellent: no septal artefact. Higher
scores therefore indicated less artefact and higher image
quality.
Reproducibility
In order to compare reproducibility at 1.5 T and at 3 T,
a group of 20 patients was selected for inter-observer,
intra-observer variability and for inter-study variability.
The 20 selected patients had levels of myocardial and
liver siderosis that covered the entire range of the dis-
ease (from absent to severe iron overload). For intra-
observer variability, the same investigator was asked to
reassess myocardial iron content on WB and BB se-
quences and liver iron at 1.5 T and 3 T within a month
Fig. 4 Comparison of artefacts scores for cardiac iron content assessment according to the field strength and the type of sequence used for
image acquisition
Table 2 Coefficients of variation and intra-class correlation for intra-observer reproducibility of T2* measurements according to
acquisition sequence and magnetic field strength
Heart Liver
WB BB
CoV ICC (95 % CI) CoV ICC (95 % CI) CoV ICC (95 % CI)
1.5 T 3.19 % 0.999 (0.998–1.000) 1.54 % 1.000 (0.999–1.000) 1.98 % 0.953 (0.890–0.980)
3 T 3.54 % 0.999 (0.997–1.000) 3.62 % 0.999 (0.999–1.000) 3.62 % 0.999 (0.997–1.000)
BB Black Blood, CI Confidence Interval, CoV Coefficient of Variation, ICC Intra-class Correlation, WB White Blood
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after the first scan. For inter-observer variability two in-
vestigators experienced in MR iron content evaluation
separately reported T2* at each sequence at 1.5 T and
3 T for each selected patient. Finally, patients underwent
a repeated 3 T cardiac and liver iron content evaluation
after a period of 1 h after the previous scan, for inter-
study reproducibility assessment.
Statistical analysis
Imaging data were not normally distributed and are
therefore expressed as median (interquartile range).
Comparison of T2* and R2* values between normal vol-
unteers and iron overload patients was performed with
Mann-Whitney U-test. Association between T2* and
R2* values according to different sequence acquisition
and field strengths were evaluated with the Spearman’s
correlation coefficient with 95 % confidence interval (CI)
or non-linear regression when appropriate. Cardiac arte-
fact scoring between different acquisitions and field
strengths were compared using a Chi-Square test.
Coefficients of variation (CoV) and intra-class correl-
ation (ICC) (with 95 % CI) analysis were conducted to
assess inter- and intra-observer variability in addition to
inter-study variability of cardiac and liver T2* values at
1.5 T and 3 T. For ICC, an alpha two-way mixed model
with absolute agreement analysis was used. Statistical
comparison between BB sequence inter-and intra-
observer and inter-study reproducibility at 1.5 T and at
3 T was performed using the squared difference between
the 2 observations as an estimate of between subjects
variance and was multiplied by 2. A paired T-Test was
done to compare the different squared difference. When
appropriate, the squared differences were log trans-
formed to allow T-test use. When the difference was
zero, it was replaced by half of the next value before log
transformation [15]. Finally, Bland-Altman plots were
generated to further describe the reproducibility of T2*
measurements at 3 T [16]. A P-value <0.05 was consid-
ered significant. All analyses were done using SPSS soft-
ware version 22.0.0, IBM, Chicago, Illinois, USA.
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Fig. 5 Bland-Altman plots for intra-observer variability (Panel a) and inter-observer variability (Panel b) of White-Blood T2* measurements at 3 T
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Results
Patient characteristics and comparison with healthy
volunteers
A total of 124 subjects were included in the analysis.
Demographics, clinical characteristics and median heart
and liver T2* measurement at 1.5 T and at 3 T in both
iron overload (n = 104) and normal (n = 20) patients are
shown in Table 1. β-thalassemia major was present in
45 %. In the patients with iron overload, median age was
30 (23–53) years old. The majority of patients (73 %)
were treated with at least one iron chelating agent.
There were 7 patients with severe cardiac iron overload
(cardiac T2* < 10 ms at 1.5 T), and 45 patients with se-
vere liver iron overload (liver T2* < 3.3 ms at 1.5 T).
Liver acquisitions were not performed in 4 patients due
to a temporary scanner fault not related to the research.
Association between cardiac T2* and R2* at 1.5 T and 3 T
Using the WB sequence, the relationship between T2*
values at 1.5 T and 3 T for the heart was non-linear
with good fit (R2 = 0.954, P < 0.001) (Fig. 1a). There
was good linear correlation between R2* values at
1.5 T and at 3 T with the WB sequence (R2 = 0.971,
P < 0.001) (Fig. 1b) with near doubling (94 %) of R2*
values at 1.5 T. Association between T2* and R2*
values at 1.5 T and 3 T using the BB sequence are
displayed in Fig. 2a and b. The relationship between
BB T2* values at 1.5 T and 3 T was non-linear with
good fit (R2 = 0.931, P < 0.001). Good linear correl-
ation was found for BB R2* measurements at 1.5 T
and at 3 T (R2 = 0.979, P < 0.001) again with near
doubling (94 %) of R2* values at 1.5 T.
Association between liver T2* and R2* at 1.5 T and at 3 T
Regression graphs between T2* and R2* at 1.5 T and 3 T
for the liver are displayed in Fig. 3a and b. For T2*, an
excellent non-linear fit was found between the values
obtained at 1.5 T and at 3 T (R2 = 0.993, P < 0.001). Similar
to heart R2* values, excellent linear correlation was found
between R2* values at the two different field strengths
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Fig. 6 Bland-Altman plots for intra-observer variability (Panel a) and inter-observer variability (Panel b) of Black-Blood T2* measurements at 3 T
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(R2 = 0.993, P < 0.001) with an increase of 105 % in R2*
from 1.5 T to 3 T.
Artefact scores
Median artifact score was 4 (4–5) with the 1.5 T BB
sequence, 4 (3–4) with the 3 T WB sequence and 4 (4–
5) with the 3 T BB sequence. The artifact score was sig-
nificantly higher (higher indicates less artefact) with the
BB sequence at 1.5 T than with the WB sequence at 3 T
(P = 0.025) and the BB sequence at 3 T (P = 0.007).
Moreover, the artefact score was significantly superior
with the BB sequence at 3 T than with the WB sequence
at 3 T (P < 0.001) (Fig. 4).
Reproducibility
The evaluation of T2* intra-observer variability is shown
in Table 2. There was excellent agreement between the
repeated measurements in all sequences at both 1.5 and
3 T, with mildly increased CoV (inferior reproducibility)
at 3 T compared to 1.5 T. The Bland-Altman plots
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Fig. 7 Bland-Altman plots for intra-observer variability (Panel a) and inter-observer variability (Panel b) of Liver T2* measurements at 3 T
Table 3 Coefficients of variation and intra-class correlation for inter-observer reproducibility of T2* measurements according to
acquisition sequence and magnetic field strength
Heart Liver
WB BB
CoV ICC (95 % CI) CoV ICC (95 % CI) CoV ICC (95 % CI)
1.5 T 3.34 % 0.999 (0.998–1.000) 2.76 % 0.999 (0.999–1.000) 4.24 % 1.000 (0.999–1.000)
3 T 5.50 % 0.998 (0.990–0.998) 4.01 % 0.999 (0.998–1.000) 3.96 % 0.999 (0.996–1.000)
BB Black Blood, CI Confidence Interval, CoV Coefficient of Variation, ICC Intra-class Correlation, WB White Blood
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confirm that there was no systemic bias in repeated as-
sessment of T2* at 3 T by the same observer (Figs. 5a, 6a,
7a).
Table 3 displays the CoV and ICC for estimation of T2*
inter-observer variability. There was excellent agreement
between the two observers. Bland-Altman plots confirms
the agreement between the observers at 3 T (Figs. 5b, 6b
and 7b) without the presence of systematic bias. Finally,
inter-study reproducibility was excellent as shown in
Table 4. CoV was found to be slightly inferior at 3 T than
at 1.5 T. Overall, at 3 T, the BB imaging sequence had less
variability of cardiac T2* measurements than the WB se-
quence but this did not achieve statistical significance
(Table 5).
Discussion
The main findings of the study are: a) T2* shortening
and increased B0 and B1 inhomogeneities may make
T2* quantification at 3 T difficult in high iron loading;
b) The correlations between T2* and R2* values between
1.5 T and 3 T are high; c) Good image quality was
achieved at 3 T but was associated with significantly
more artefacts than conventional BB 1.5 T imaging; d)
There was a trend towards T2* measurements at 3 T be-
ing less reproducible than at 1.5 T.
To our knowledge, this is the largest study of transfusion
dependent patients reporting the association between T2*
and R2* values at 1.5 T and 3 T. Meloni reported on 38
patients transfusion dependent patients and showed good
correlation between WB mid-ventricular septal cardiac
R2*at 1.5 T and 3 T (R2 = 0.934) [8]. The authors also re-
ported on the correlation between liver R2* at 3 T vs
1.5 T. Unfortunately, in their study the data from five
patients with high iron overload (high R2*) had to be
excluded to respect the best-fit correlation analysis.
The present study includes all 45 patients with severe
liver iron overload at 1.5 T and used a second order
truncation method to obtain reliable T2* values at 3 T
in all these patients, with good associations between
1.5 T and 3 T values [14].
Guo quantified liver and cardiac T2 and T2* at 3 T in
24 patients and eight normal subjects [9]. The T2* value
could not be reliably be determined using their BB
3 T T2* protocol in certain severely iron overloaded
patients with heart or liver T2* <2 ms (heart n = 6; liver
n = 8). Thus, reliable 3 T T2* values in high-risk pa-
tients were not always obtainable. Storey also expressed
concerns over T2* and R2* quantification at 3 T [10].
Indeed, inadequate shimming and the ultrashort echo
times needed to appropriately assess very low T2* at
3 T may produce inaccuracies in T2* quantification.
Moreover, the increase in RF power deposition at 3 T
limits the capacity to increase RF gradients. Our study
also showed that cardiac 3 T T2* acquisition is associ-
ated with poorer image quality (artefact scores lower)
for both WB and BB which resulted in less good repro-
ducibility at 3 T than at 1.5 T. This important issue
may hamper patient care and therefore T2* assessment
at 1.5 T remains the clinical test of choice. At centres
where only 3 T scanners are available, then it would be
reasonable to convert the 3 T value for T2* to a value
that approximates to what would be expected at 1.5 T,
but safeguards must be in place to ensure that the T2*
value at 3 T has been obtained without compromise re-
lated to artefact and analysis. This is best performed by
halving the R2* value at 3 T and divide into 1000 to es-
timate the T2* equivalent at 1.5 T. Another possible ap-
proach to assessing iron loading at 3 T is to use native T1
mapping, but this needs further research [17].
Limitations
The present study was conducted in a single centre with
experience in T2* assessment. The relatively low CoV
and high ICC values obtained should ideally be com-
pared to the reproducibility data from other centres.
One advantage conferred by 3 T MR may not have
been fully explored in the present study, which is the
possible increase of the acceleration factor and conse-
quent shortening of the acquisition time. Such an
Table 4 Coefficients of variation and intra-class correlation for inter-study reproducibility of T2* measurements according to acquisition
sequence and magnetic field strength
Cardiac Liver
WB BB
CoV ICC (95 % CI) CoV ICC (95 % CI) CoV ICC (95 % CI)
1.5 T 5.55 % 0.996 (0.989–0.998) 4.55 % 0.994 (0.985–0.998) 5.69 % 0.979 (0.949–0.992)
3 T 7.68 % 0.970 (0.926–0.988) 6.48 % 0.996 (0.990–0.998) 6.31 % 0.998 (0.993–0.999)
BB Black Blood, CI Confidence Interval, CoV Coefficient of Variation, ICC Intra-class Correlation, WB White Blood
Table 5 Reproducibility of Black Blood T2* at 1.5 T and 3 T
Test Geometric Mean (95 % CI) of Squared
difference
P-value
T2* BB 1.5 T T2* BB 3 T
Intra-Observer 0.04 (0.02, 0.09) 0.07 (0.03, 0.15) 0.26
Inter-Observer 0.04 (0.01, 0.12) 0.07 (0.02, 0.21) 0.18
Inter study 0.26 (0.08, 0.80) 0.28 (0.09, 0.82) 0.94
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increase in image acquisition speed however, may lead
to reduction in signal to noise ratio and loss of image
quality. Only adults >18 years were studied in this re-
search which may limit the conclusions that may be
drawn in younger and smaller patients.
Conclusion
In transfusion dependent anaemia patients, heart and
liver T2* and R2* quantification is feasible at 3 T. Good
associations were obtained between values at 3 T and at
1.5 T with good reproducibility at both field strengths.
However, no clear advantage of T2* imaging at 3 T could
be identified and the clinical routine of T2* MR being
performed at 1.5 T remains clinically optimal and should
continue. Where only 3 T is available, one option for iron
quantification is to halve the tissue R2* found at 3 T,
and divide into 1000 to estimate the equivalent T2* value
which would have been found at 1.5 T. However, great
care must be taken to ensure that the T2* value at 3 T is
not compromised by artefact or analysis difficulty.
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